167 related articles for article (PubMed ID: 7594663)
21. Antibodies against Haemophilus influenzae type b and tetanus in infants after subcutaneous vaccination with PRP-T/diphtheria, or PRP-OMP/diphtheria-tetanus vaccines.
Carlsson RM; Claesson BA; Iwarson S; Lagergård T; Käyhty H
Pediatr Infect Dis J; 1994 Jan; 13(1):27-33. PubMed ID: 8170729
[TBL] [Abstract][Full Text] [Related]
22. Comparison of naturally acquired and vaccine-induced antibodies to Haemophilus influenzae type b capsular polysaccharide.
Jelonek MT; Chang SJ; Chiu CY; Park MK; Nahm MH; Ward JI
Infect Immun; 1993 Dec; 61(12):5345-50. PubMed ID: 8225608
[TBL] [Abstract][Full Text] [Related]
23. Safety and immunogenocity of a novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C-tetanus-toxoid conjugate vaccine in healthy Chinese children aged 6 months to 5 years old.
Hu JL; Tao H; Li JX; Dai WM; Song B; Sun JF; Liu P; Tang J; Liu WY; Wang SY; Zhu FC
Hum Vaccin Immunother; 2015; 11(5):1120-8. PubMed ID: 25833163
[TBL] [Abstract][Full Text] [Related]
24. A novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus-toxoid conjugate vaccine is immunogenic and induces immune memory when co-administered with DTPa-HBV-IPV and conjugate pneumococcal vaccines in infants.
Nolan T; Lambert S; Roberton D; Marshall H; Richmond P; Streeton C; Poolman J; Boutriau D
Vaccine; 2007 Dec; 25(51):8487-99. PubMed ID: 17996996
[TBL] [Abstract][Full Text] [Related]
25. Immunogenicity, reactogenicity, and immune memory after primary vaccination with a novel Haemophilus influenzae-Neisseria meningitidis serogroup C conjugate vaccine.
Schmitt HJ; Maechler G; Habermehl P; Knuf M; Saenger R; Begg N; Boutriau D
Clin Vaccine Immunol; 2007 Apr; 14(4):426-34. PubMed ID: 17287313
[TBL] [Abstract][Full Text] [Related]
26. Postlicensure effectiveness of the Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer-membrane protein complex conjugate vaccine among Navajo children.
Harrison LH; Tajkowski C; Croll J; Reid R; Hu D; Brenneman G; Weatherholtz RC; Santosham M
J Pediatr; 1994 Oct; 125(4):571-6. PubMed ID: 7931875
[TBL] [Abstract][Full Text] [Related]
27. The induction of immunologic memory after vaccination with Haemophilus influenzae type b conjugate and acellular pertussis-containing diphtheria, tetanus, and pertussis vaccine combination.
Goldblatt D; Richmond P; Millard E; Thornton C; Miller E
J Infect Dis; 1999 Aug; 180(2):538-41. PubMed ID: 10395878
[TBL] [Abstract][Full Text] [Related]
28. The development of a new heptavalent diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components.
Gatchalian S; Palestroque E; De Vleeschauwer I; Han HH; Poolman J; Schuerman L; Dobbelaere K; Boutriau D
Int J Infect Dis; 2008 May; 12(3):278-88. PubMed ID: 17981067
[TBL] [Abstract][Full Text] [Related]
29. Comparative immunogenicity of four Haemophilus influenzae type b conjugate vaccines in Alaska Native infants.
Bulkow LR; Wainwright RB; Letson GW; Chang SJ; Ward JI
Pediatr Infect Dis J; 1993 Jun; 12(6):484-92. PubMed ID: 8345981
[TBL] [Abstract][Full Text] [Related]
30. Haemophilus influenzae type b-outer membrane protein complex glycoconjugate vaccine induces cytokine production by engaging human toll-like receptor 2 (TLR2) and requires the presence of TLR2 for optimal immunogenicity.
Latz E; Franko J; Golenbock DT; Schreiber JR
J Immunol; 2004 Feb; 172(4):2431-8. PubMed ID: 14764714
[TBL] [Abstract][Full Text] [Related]
31. The immunogenicity of three Haemophilus influenzae type B conjugate vaccines after a primary vaccination series in Philippine infants.
Capeding MR; Nohynek H; Pascual LG; Kayhty H; Sombrero LT; Eskola J; Ruutu P
Am J Trop Med Hyg; 1996 Nov; 55(5):516-20. PubMed ID: 8940983
[TBL] [Abstract][Full Text] [Related]
32. Transplacental antibody transfer following maternal immunization with polysaccharide and conjugate Haemophilus influenzae type b vaccines.
Englund JA; Glezen WP; Turner C; Harvey J; Thompson C; Siber GR
J Infect Dis; 1995 Jan; 171(1):99-105. PubMed ID: 7798688
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of De-O-acetylated meningococcal C polysaccharide-tetanus toxoid conjugate vaccine in infancy: reactogenicity, immunogenicity, immunologic priming, and bactericidal activity against O-acetylated and De-O-acetylated serogroup C strains.
Richmond P; Borrow R; Findlow J; Martin S; Thornton C; Cartwright K; Miller E
Infect Immun; 2001 Apr; 69(4):2378-82. PubMed ID: 11254596
[TBL] [Abstract][Full Text] [Related]
34. Five-year antibody persistence and safety following a booster dose of combined Haemophilus influenzae type b-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine.
Tejedor JC; Merino JM; Moro M; Navarro ML; Espín J; Omeñaca F; García-Sicilia J; Moreno-Pérez D; Ruiz-Contreras J; Centeno F; Barrio F; Cabanillas L; Muro M; Esporrin C; De Torres MJ; Caubet M; Boutriau D; Miller JM; Mesaros N
Pediatr Infect Dis J; 2012 Oct; 31(10):1074-7. PubMed ID: 22828645
[TBL] [Abstract][Full Text] [Related]
35. Safety and immunogenicity of PRP-T combined with DTP: excretion of capsular polysaccharide and antibody response in the immediate post-vaccination period.
Miller MA; Meschievitz CK; Ballanco GA; Daum RS
Pediatrics; 1995 Apr; 95(4):522-7. PubMed ID: 7700752
[TBL] [Abstract][Full Text] [Related]
36. Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines. The Vaccine Study Group.
Schlesinger Y; Granoff DM
JAMA; 1992 Mar; 267(11):1489-94. PubMed ID: 1538539
[TBL] [Abstract][Full Text] [Related]
37. Safety and immunogenicity of a Haemophilus influenzae type b conjugate vaccine in a high risk American Indian population.
Santosham M; Hill J; Wolff M; Reid R; Lukacs L; Ahonkhai V
Pediatr Infect Dis J; 1991 Feb; 10(2):113-7. PubMed ID: 2062601
[TBL] [Abstract][Full Text] [Related]
38. Preclinical studies on a recombinant group B meningococcal porin as a carrier for a novel Haemophilus influenzae type b conjugate vaccine.
Fusco PC; Michon F; Laude-Sharp M; Minetti CA; Huang CH; Heron I; Blake MS
Vaccine; 1998 Nov; 16(19):1842-9. PubMed ID: 9795390
[TBL] [Abstract][Full Text] [Related]
39. An enzyme-linked immunosorbent assay for quantitation of Haemophilus Influenzae type b polysaccharide-specific IgG1 and IgG2 in human and infant rhesus monkey sera.
Dolan KT; Staub JM; Schofield TL; Ahonkhai VI; Ellis RW; Vella PP
J Immunoassay; 1991; 12(4):543-64. PubMed ID: 1806588
[TBL] [Abstract][Full Text] [Related]
40. Immunogenicity and safety of two different Haemophilus influenzae type b conjugate vaccines in Korean infants.
Kim KH; Lee H; Chung EH; Kang JH; Kim JH; Kim JS; Lee HJ; Oh SH; Park EA; Park SE
J Korean Med Sci; 2008 Dec; 23(6):929-36. PubMed ID: 19119431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
